Thrivent Financial for Lutherans’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-115,100
Closed -$1.65M 2464
2021
Q3
$1.65M Sell
115,100
-370
-0.3% -$5.32K ﹤0.01% 1481
2021
Q2
$1.83M Buy
+115,470
New +$1.83M ﹤0.01% 1474